FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Barostim Neo Regulatory Review Determined

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for CVRxs Barostim Neo, indicated for improving sym...

Federal Register

Product-specific Bioequivalence Guides Availability

Federal Register notice: FDA makes available additional draft and revised draft product-specific guidances that discuss the design of bioequivalence s...

Federal Register

FDA Seeks Consumer Reps on Advisory Panels

Federal Register notice: FDA requests that any consumer organizations interested in participating in the selection of voting and nonvoting consumer re...

Medical Devices

Rapid Medical Clot Retriever Clearance

FDA clears a Rapid Medical 510(k) for its TigerTriever revascularization device for use in treating ischemic stroke.

Human Drugs

Serono Comments on Planned FDA Disease Progression Workshop

EMD Serono suggests three topics for FDA consideration for an upcoming workshop on best practices for developing and applying disease progression mode...

Biologics

Objectionable Conditions at Nevada Clinical Study Site

FDA cautions Michael Levin for violations in his work as a clinical investigator for a clinical study.

Medical Devices

FDA Clears Aurora Spine Cervical Plate

FDA clears an Aurora Spine 510(k) for its proprietary Apollo Anterior Cervical Plate system, featuring a 1.9mm design with hyper-angulation variabilit...

Human Drugs

Exela Wants Nicardipine PDUFA Fee Refund

Exela petitions FDA to reassign a therapeutic equivalence code to its nicardipine NDA product and refund PDUFA user fees that it believes should not h...

Federal Register

FDA Revises Bulk Drug Substances Listing

Federal Register notice: FDA revises its list of bulk drug substances (active pharmaceutical ingredients) for which there is a clinical need in drug c...

Federal Register

Workshop on Generic Drug Science/Research Initiatives

Federal Register notice: FDA announces a 6/23 public workshop entitled FY 2021 Generic Drug Science and Research Initiatives Workshop.